0.60Open1.10Pre Close58 Volume101 Open Interest78.00Strike Price2.60KTurnover57.72%IV1.15%PremiumDec 13, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.33Extrinsic Value100Contract SizeAmericanOptions Type0.2544Delta0.4875Gamma774.40Leverage Ratio-1.3596Theta0.0000Rho197.03Eff Leverage0.0037Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet